stars 1 stars 2 stars 3

Indigo Diabetes N.V. (Indigo) is a pioneering developer of medical devices for people living with chronic diseases. Using its proprietary nanophotonics technology the Company is developing the world’s first subcutaneously implanted Continuous Multi-Metabolite Monitoring (CMM®) sensor to provide people living with chronic diseases access to information on their metabolite levels at any time, without the need to wear an external device on their body. Indigo is initially focused on diabetes to address the need for continuous and accurate glucose, ketone, and lactate monitoring. Indigo is headquartered in Ghent, Belgium, and also has employees based in the US.

Indigo Questions

The Indigo annual revenue was $4 million in 2026.

Emmet Lydon is the Chief Operating Officer at Indigo Diabetes of Indigo.

22 people are employed at Indigo.

The NAICS codes for Indigo are [33, 334].

The SIC codes for Indigo are [38, 384].

Top Indigo Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users